Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma

.

Source: OncoImmunology - February 27, 2019 Category: Cancer & Oncology Authors: Nusrat Jahan Hammad Talat Andrea Alonso Dipongkor Saha William T. Curry Source Type: research